ðŠðº ããŒã¹ã·ã§ã¢: åœå åã®ç¡éã¯ã¯ãã³ã»ãããæœèšãªãŒãã³
以äžã®æç« ã¯ãå人çãªè©Šèš³ã§ãïŒ
ããŒã¹ã·ã§ã¢ã«åœå åã®ç¡éã¯ã¯ãã³ã»ãããæœèšããªãŒãã³
å¯éŠçžå
Œå·éçºã»ã€ã³ãã©ã»å°æ¹æ¿åºã»èšç»æ
åœå€§è£å
Œããªãªã³ããã¯ã»ãã©ãªã³ããã¯ç«¶æ倧äŒã€ã³ãã©æ
åœéŠçžè£äœå€§è£
ã¹ãã£ãŒãã³ã»ãã€ã«ãºå士
1)ãŽã¡ã¯ãµã¹ç€Ÿãæ°æœèšã§éãªãã¯ã¯ãã³ãããæè¡ã®è£œé ã匷å
2)ãã©ã·ã¥ãã¯å·æ¿åºã¯ãå·çµæžã掻æ§åããããªãŒã¹ãã©ãªã¢åã®ãããžã§ã¯ããæ¯æŽã
3)æ¥æé·ããäžççç£æ¥ã§ãæ倧2,00人ã®å°å
éçšãšæèœéçšãæ¯æŽããã
ã¯ã€ãŒã³ãºã©ã³ãå·ã®çµæžã«æ°åãã«ã泚å
¥ãããéã䜿ããªãã¯ã¯ãã³æè¡è£œé æœèšãããŒã¹ã·ã§ã¢ã»ããã«ãã³ã«å®æã
ã¯ã€ãŒã³ãºã©ã³ãå·ã®ãã€ãªãã¯ãããžãŒäŒæ¥Vaxxas瀟ã¯ãä»åŸ3幎ã5幎ã®éã«ãããªã¹ãã³ã®æ°å·¥å Žã§ãæ°çŸäžåã®éã䜿ããªãã¯ã¯ãã³ãããã補é ããäºå®ã
ã¹ãã£ãŒãã³ã»ãã€ã«ãºå¯éŠçžã¯ããã©ã·ã¥ãã¥ã¯æ¿åºã®æ¯æŽã«ãã建èšããããæå
端ãã€ãªã¡ãã£ã«ã«è£œé æœèšã®å
¬åŒãªãŒããã³ã°ã®çºãæ¬æ¥çŸå°ã蚪åã
ãŽã¡ã¯ãµã¹ã®äžçããªãŒãããã¯ã¯ãã³ãããæè¡ã¯ããããæ°ç§ã§ç®èè¡šé¢ããã¯ã¯ãã³ãæäžããããšãã§ããã
ãã®ãããžã§ã¯ãã¯ãä»åŸ3幎ã5幎ã®éã«ãå°å
ã§æ倧200人ã®çç·ŽããéçšããµããŒãããããšãæåŸ
ãããŠãããäžççã«ç«¶äºåã®ããã¢ãžã¢å€ªå¹³æŽå°åã®ãã€ãªã¡ãã£ã«ã«ã»ãããšããŠãã¯ã€ãŒã³ãºã©ã³ãå·ã®å°äœãé«ãŸã£ãŠããã
ã¯ã€ãŒã³ãºã©ã³ãå·æ¿åºã¯ãããŒã¹ã·ã§ã¢ã«ããæ¢åã®å庫ãæ¹è£
ããæå
端ã®æœèšã«çãŸãå€ããããçºããŽã¡ã¯ãµã¹ã«è³éæŽå©ãšéå¶æ¯æŽãè¡ã£ãã
æ¬æ¥ã®ãªãŒãã³ã¯ãããŒã¹ã·ã§ã¢ã»ããã«ãã³éç¹éçºå°åã®å€é©ã«ãããæ°ããªãã€ã«ã¹ããŒã³ãšãªãã
ãŽã¡ã¯ãµã¹ã¯ãããŒããµã€ããããªã¹ãã³ã»ãã¯ãããžãŒã»ããŒã¯ãã€ãŒãã»ã¹ããªãŒãã»ããŒã±ãããšãã£ãå°åºãšãšãã«ããŠãããŒãµã«ã»ãã£ãŒã«ãã»ããããã®ãããªé©æ°çããžãã¹ã®æ ç¹ã«å ããã
ããŒã¹ã·ã§ã¢ããã«ãã³ã¯ãããªã¹ãã³2032ãªãªã³ããã¯ã»ãã©ãªã³ããã¯ç«¶æ倧äŒã®ããªã¹ãã³éžææã®å°æ¥ã®æ ç¹ã§ãããã
åŒçš: ã¹ãã£ãŒãã³ã»ãã€ã«ãºå¯éŠçž
ãã¯ã€ãŒã³ãºã©ã³ãå·ã¯ããã©ã·ã¥ãã¥ã¯æ¿æš©ããã®ãããªæå
端ã®æœèšã«æè³ãããããã§ãäžççãªç 究ãšã€ãããŒã·ã§ã³ã®æ ç¹ãšããŠæ¥éã«çºå±ããŠããããšè¿°ã¹ãã
ãã¯ã€ãŒã³ãºã©ã³ãå·çµæžéçºå±ã¯ããã®æœèšã®èšèšãšèªå¯ãé²ããçºã«ãŽã¡ã¯ãµã¹ãšç·å¯ã«ååããŠããã
ããã©ã·ã¥ãã¥ã¯æ¿åºã¯ãèªåœã®ãã€ãªã¡ãã£ã«ã«æ°èäŒæ¥ãé 調ã«ã¹ã±ãŒã«ã¢ããã§ããããæ¯æŽããã€ãããŒã·ã§ã³ãšåªç§ãªç 究è
ãèªåœå
ã§ç¶æã§ããããå°œåããã
ãŽã¡ã¯ãµã¹ã¯ãæ¥æé·ããäžççãªç£æ¥ã§é«åºŠãªæè¡ãèŠããéçšãåµåºããå·çµæžã掻æ§åããããå°å
ã®ãµã¯ã»ã¹ã¹ããŒãªãŒã®çŽ æŽãããäŸã§ãããã
ãã¯ã¯ãã³éçºã補é ãäŸçµŠã«ããã䞻暩èœåãæ¡å€§ããããšã¯ãCOVID-19ãç§ãã¡ã«æããŠãããéèŠãªæèšã®ã²ãšã€ã§ããã
ããã®äžççã«æåãªæè¡ã¯ããã³ãããã¯å¯Ÿçã«ãããŠéèŠãªåœ¹å²ãæããå¯èœæ§ãç§ããŠããã
ãã®æ°æœèšããã¯ã€ãŒã³ãºã©ã³ãå·æ倧ã®éœåžåéçºå°åºãšããŠç®èŠããå€è²ãéãã€ã€ããããŒã¹ã·ã§ã¢ã»ããã«ãã³ã§çšŒåããã®ãèŠãã®ã楜ãã¿ã§ããã
ãã¯ã€ãŒã³ãºã©ã³ãå·ã¯ãç§åŠåéã§åããæè³ããå ŽæãšããŠããŸããŸãåãå¢ããŠãããã
åŒçš: ãŽã¡ã¯ãµã¹æé«çµå¶è²¬ä»»è
ããããã»ããŒã€ã«åž°å±
ããã®æœèšã®éèšã¯ãã¯ã€ãŒã³ãºã©ã³ã倧åŠã®ç 究ã«åºã¥ããŠ2011幎ã«èšç«ããããã¯ãµã¹ã«ãšã£ãŠéèŠãªç¯ç®ãšãªãã
ã¯ã€ãŒã³ãºã©ã³ãå·æ¿åºãšãªãŒã¹ãã©ãªã¢é£éŠæ¿åºã®æ¯æŽã«ããããŽã¡ã¯ãµã¹ã»ãã€ãªã¡ãã£ã«ã«ã»ãã¡ã·ãªãã£ãŒã¯ããªãŒã¹ãã©ãªã¢ãã¯ã¯ãã³æè¡é©æ°ã®æåç·ã«äœçœ®ã¥ããããšã«ãªãã ããã
ããã®æœèšã¯ãåœç€Ÿã®è£œé èœåã倧å¹
ã«åäžãããå°å
ã§çç·Žããæ°ããªéçšãåµåºãããšåæã«ããŽã¡ã¯ãµã¹ãåŸæèšåºè©Šéšãé²ããåœç€Ÿåã®åæ¥çšã¯ã¯ãã³è£œåãåžå Žã«æå
¥ããããšãå¯èœã«ããã
ã500人以äžãåå ããããèšåºè©Šéšãå®äºããCOVID-19ãšå£ç¯æ§ã€ã³ãã«ãšã³ã¶ã察象ãšãããªãŒã¹ãã©ãªã¢ã§ã®ç¬¬Içžèšåºè©Šéšãé²è¡äžã§ããã»ããç±³åœæ¿åºã®è³éæäŸã«ãããã³ããã㯠ã€ã³ãã«ãšã³ã¶ã察象ãšããã¯ã¯ãã³è©Šéšããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã®è³éæäŸã«ãã麻ç¹é¢šç¹è©Šéšã2024幎ã«éå§ãããäºå®ã§ãããªã©ããŽã¡ã¯ãµã¹ã®ã¯ã¯ãã³ãããæè¡ãã©ãããã©ãŒã ã¯åæ¥åã«åããŠæ¥éã«åé²ããŠããã
ãç§ãã¡ã¯ããã®ã¯ã€ãŒã³ãºã©ã³ãå·ã®æœèšããã3幎ã5幎以å
ã«ãåæ¥çã«å©çšå¯èœãªæåã®éã䜿ããªãã¯ã¯ãã³ãããã補é ãã販売ããããšãæåŸ
ããŠãããã
ãã®ä»ã®äºå®
1)ãŽã¡ã¯ãµã¹ãããžã§ã¯ãã¯ãã¯ã€ãŒã³ãºã©ã³ãå·æ¿åºã®ãã€ãªã¡ãã£ã«ã«10幎ããŒãããããšã¢ã¯ã·ã§ã³ãã©ã³ã«æ²¿ã£ããã®ã§ããã
2)ãã€ãªã¡ãã£ã«ã«éšéã¯ãã¯ã£ãŒã³ãºã©ã³ãå·çµæžã«21åãã«è²¢ç®ãã12,000人以äžãéçšã
3)ã¯ã€ãŒã³ãºã©ã³ãå·ãã€ãªã¡ãã£ã«ã«ã»ããžãã¹èªèŽããã°ã©ã ã¯ãéããªãéå§ãããã
ãã®èšäºãæ°ã«å ¥ã£ãããµããŒããããŠã¿ãŸãããïŒ